SAVA – cassava sciences, inc. (US:NASDAQ)

News

Cassava Sciences (NASDAQ:SAVA) was upgraded by analysts at Wall Street Z
Cassava Sciences (NASDAQ:SAVA) was downgraded by analysts at Wall Street
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
Cassava Sciences (NASDAQ:SAVA) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com